The Effects of Polyphenol-Rich Black Elderberry on Oxidative Stress and Hepatic Cholesterol Metabolism
Source abstract
Abstract
Black elderberry (Sambucus Nigar) with high polyphenol content has been reported to have a hypolipidemic effect, but its underlying mechanisms have not been well characterized. In the present study, we investigated the effects of polyphenol-rich black elderberry (BEE) on oxidative stress and hepatic lipid metabolism. The total antioxidant activity of BEE was evaluated. The expression of genes for lipid metabolism was measured in 50 or 100 μg/mL of BEE-treated HepG2 cells. The mRNA and protein levels of genes for cholesterol metabolisms, i.e., sterol regulatory element-binding protein 2, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and low-density lipoprotein receptor, were decreased by BEE. There was marked induction of genes for high-density lipoprotein metabolism, i.e., scavenger receptor class B type 1and ATP-binding cassette (ABC) transporter A1 in BEE-treated cells. The expression of canalicular efflux transporter for hepatic cholesterol and bile acids, such as ABCG5/G8 and ABCB11, was significantly increased by BEE treatment. There was no alteration of the lipogenic genes, whereas BEE significantly decreased the expression of genes for fatty acid oxidation. BEE significantly altered the expression of histone deacetylase and sirtuins. These data suggest that the hypocholesterolemic effects of BEE may be attributed to the alteration of genes for hepatic cholesterol synthesis and flux.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cholesterol and Lipid Metabolism · Free Radicals and Antioxidants · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Food Science and Nutrition, Pusan National University, Busan 46241, Korea
Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Korea
Funding
Pusan National University
References (77)
Show source-provided references
1. Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association10.1161/CIR.0000000000000950 ↗
2. Health status as a risk factor in cardiovascular disease: A systematic review of current evidence10.1016/j.ahj.2008.09.020 ↗
3. Hyperlipidemia as a Risk Factor for Cardiovascular Disease10.1016/j.pop.2012.11.003 ↗
4. Mechanisms and regulation of cholesterol homeostasis10.1038/s41580-019-0190-7 ↗
5. Cross-talk between liver and intestine in control of cholesterol and energy homeostasis10.1016/j.mam.2014.02.001 ↗
6. Cholesterol metabolism in humans: A review of methods and comparison of results10.1097/MOL.0000000000000475 ↗
7. Transintestinal cholesterol excretion: A secondary, nonbiliary pathway contributing to reverse cholesterol transport10.1002/hep.29341 ↗
8. A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport
9. A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion10.1016/j.tips.2015.04.002 ↗
10. The TICE Pathway: Mechanisms and Lipid-Lowering Therapies10.14797/mdcj-15-1-70 ↗
11. Statin-associated ocular disorders: The FDA and ADRAC data10.1007/s11096-015-0128-x ↗
12. Update on statin drugs for lipid disorders10.1016/j.gerinurse.2018.04.016 ↗
13. Statin treatment and muscle disorders10.1556/oh.2009.28520 ↗
14. Cholesterol Lowering and Stroke: No Longer Room for Pleiotropic Effects of Statins–Confirmation from PCSK9 Inhibitor Studies10.1016/j.amjmed.2019.06.029 ↗
15. Side effects of fibrates (except liver and muscle)
16. Total polyphenol intake, polyphenol subtypes and incidence of cardiovascular disease: The SUN cohort study10.1016/j.numecd.2018.09.012 ↗
17. Rienks, J., Barbaresko, J., and Nöthlings, U. (2017). Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients, 9.10.3390/nu9040415 ↗
18. Beneficial effects of polyphenols on cardiovascular disease10.1016/j.phrs.2012.10.018 ↗
19. Polyphenols can Potentially Prevent Atherosclerosis and Cardiovascular Disease by Modulating Macrophage Cholesterol Metabolism10.2174/1874467213666200320153410 ↗
20. Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease10.2174/1381612825666190722100504 ↗
21. Polyphenols, Inflammation, and Cardiovascular Disease10.1007/s11883-013-0324-x ↗
22. The polyphenols, naturally occurring compounds with beneficial effects on cardiovascular disease
23. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines
24. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry10.1016/j.jff.2017.11.025 ↗
25. Młynarczyk, K., Walkowiak-Tomczak, D., Staniek, H., Kidoń, M., and Łysiak, G.P. (2020). The Content of Selected Minerals, Bioactive Compounds, and the Antioxidant Properties of the Flowers and Fruit of Selected Cultivars and Wildly Growing Plants of Sambucus nigra L.. Molecules, 25.10.20944/preprints202001.0141.v1 ↗
26. Elderberry (Sambucus nigra L.) as potential source of antioxidants. Characterization, optimization of extraction parameters and bioactive properties10.1016/j.foodchem.2020.127266 ↗
27. Zielińska-Wasielica, J., Olejnik, A., Kowalska, K., Olkowicz, M., and Dembczyński, R. (2019). Elderberry (Sambucus nigra L.) Fruit Extract Alleviates Oxidative Stress, Insulin Resistance, and Inflammation in Hypertrophied 3T3-L1 Adipocytes and Activated RAW 264.7 Macrophages. Foods, 8.10.3390/foods8080326 ↗
28. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract10.1016/j.colsurfb.2014.08.018 ↗
29. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice10.1039/C4FO01036A ↗
30. Olivas-Aguirre, F.J., Rodrigo-García, J., Martínez-Ruiz, N.D.R., Cárdenas-Robles, A.I., Mendoza-Díaz, S.O., Alvarez-Parrilla, E., Gonzalez-Aguilar, G.A., De la Rosa, L.A., Ramos-Jimenez, A., and Wall-Medrano, A. (2016). Cyanidin-3-O-glucoside: Physical-chemistry, foodomics and health effects. Molecules, 21.10.3390/molecules21091264 ↗
31. Strugała, P., Loi, S., Bażanów, B., Kuropka, P., Kucharska, A.Z., Włoch, A., and Gabrielska, J. (2018). A Comprehensive Study on the Biological Activity of Elderberry Extract and Cyanidin 3-O-Glucoside and Their Interactions with Membranes and Human Serum Albumin. Molecules, 23.10.3390/molecules23102566 ↗
32. Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice10.1017/S0007114515002962 ↗
33. Jeon, S., Kim, M., and Kim, B. (2021). Polyphenol-Rich Black Elderberry Extract Stimulates Transintestinal Cholesterol Excretion. Appl. Sci., 11.10.3390/app11062790 ↗
34. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals10.1016/S0308-8146(98)00102-2 ↗
35. Acylated anthocyanins from edible sources and their applications in food systems10.1016/S1369-703X(02)00221-8 ↗
36. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay10.1006/abio.1996.0292 ↗
37. Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice10.1186/1476-511X-11-56 ↗
38. Herbal Medicine for the Treatment of Cardiovascular Disease10.1001/archinte.158.20.2225 ↗
39. Herbal drugs against cardiovascular disease: Traditional medicine and modern development10.1016/j.drudis.2015.04.009 ↗
40. Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol10.1016/j.plipres.2008.03.001 ↗
41. Long-Term Supplementation of Black Elderberries Promotes Hyperlipidemia, but Reduces Liver Inflammation and Improves HDL Function and Atherosclerotic Plaque Stability in Apolipoprotein E-Knockout Mice10.1002/mnfr.201800404 ↗
42. Sterol metabolism and SREBP activation10.1016/j.abb.2010.06.004 ↗
43. Srebp2: A master regulator of sterol and fatty acid synthesis10.1194/jlr.C066712 ↗
44. Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake10.1111/j.1753-4887.1998.tb01680.x ↗
45. News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 110.1097/MOL.0000000000000411 ↗
46. Wong, T.Y., Lin, S.-M., and Leung, L.K. (2015). The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells. PLoS ONE, 10.10.1371/journal.pone.0135637 ↗
47. Barley sprout extract containing policosanols and polyphenols regulate AMPK, SREBP2 and ACAT2 activity and cholesterol and glucose metabolism in vitro and in vivo10.1016/j.foodres.2015.03.041 ↗
48. Red raspberry extract (Rubus idaeus L shrub) intake ameliorates hyperlipidemia in HFD-induced mice through PPAR signaling pathway10.1016/j.fct.2019.110796 ↗
49. SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis10.1016/j.tem.2017.02.001 ↗
50. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux10.1146/annurev-physiol-021317-121550 ↗
51. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
52. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations10.1194/jlr.M200414-JLR200 ↗
53. Origins of intestinal ABCA1-mediated HDL-cholesterol10.1194/jlr.M800302-JLR200 ↗
54. Quercetin induces the selective uptake of HDL-cholesterol via promoting SR-BI expression and the activation of the PPARγ/LXRα pathway10.1039/C7FO01107E ↗
55. Ethanolic Extract of Propolis Promotes Reverse Cholesterol Transport and the Expression of ATP-Binding Cassette Transporter A1 and G1 in Mice10.1007/s11745-011-3568-7 ↗
56. Effect of alcohol-free red wine concentrates on cholesterol homeostasis: An in vitro and in vivo study10.1016/j.procbio.2013.09.007 ↗
57. Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport10.1146/annurev-physiol-012110-142233 ↗
58. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)10.1073/pnas.0500269102 ↗
59. Ezetimibe Blocks Internalization of the NPC1L1/Cholesterol Complex10.1016/j.cmet.2008.05.001 ↗
60. Cholesterol and non-cholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1: A review10.1080/00498250802007930 ↗
61. Biliary cholesterol secretion: More than a simple ABC
62. Cholesterol transporter proteins in HepG2 cells can be modulated by phenolic compounds present in Opuntia ficus-indica aqueous solutions10.1016/j.jff.2019.103674 ↗
63. Coffea arabica pulp aqueous extract attenuates oxidative stress and hepatic lipid accumulation in HepG2 cells10.1016/j.hermed.2021.100465 ↗
64. Regulation of bile acid synthesis: Pathways, nuclear receptors, and mechanisms10.1016/j.jhep.2003.11.006 ↗
65. Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells10.1248/bpb.b18-00028 ↗
66. Mechanistic insights into geniposide regulation of bile salt export pump (BSEP) expression10.1039/C8RA06345A ↗
67. Bile Salt Export Pump (BSEP/ABCB11): Trafficking and Sorting Disturbances10.2174/18744672113069990036 ↗
68. Chambers, K.F., Day, P.E., Aboufarrag, H.T., and Kroon, P.A. (2019). Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review. Nutrients, 11.10.3390/nu11112588 ↗
69. Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice10.1002/mnfr.201100659 ↗
70. The role of carnitine in normal and altered fatty acid metabolism10.1016/S0272-6386(03)00112-4 ↗
71. Peroxisomal β-oxidation of Polyunsaturated Long Chain Fatty Acids in Human Fibroblasts. The Polyunsaturated and the Saturated Long Chain Fatty Acids are Retroconverted by the Same Acyl-CoA Oxidase10.3109/00365519309090698 ↗
72. Straight-Chain Acyl-CoA Oxidase Knockout Mouse Accumulates Extremely Long Chain Fatty Acids from α-Linolenic Acid: Evidence for Runaway Carousel-Type Enzyme Kinetics in Peroxisomal β-Oxidation Diseases10.1006/mgme.2001.3279 ↗
73. AoxA is a major peroxisomal long chain fatty acyl-CoA oxidase required for β-oxidation in A. nidulans10.1007/s00294-009-0286-2 ↗
74. A Combination of (ω–3) Polyunsaturated Fatty Acids, Polyphenols and L-Carnitine Reduces the Plasma Lipid Levels and Increases the Expression of Genes Involved in Fatty Acid Oxidation in Human Peripheral Blood Mononuclear Cells and HepG2 Cells10.1159/000327150 ↗
75. Epigenetic regulation of cholesterol homeostasis10.3389/fgene.2014.00311 ↗
76. Histone and DNA Methylation–Mediated Epigenetic Downregulation of Endothelial Kruppel-Like Factor 2 by Low-Density Lipoprotein Cholesterol10.1161/ATVBAHA.113.301765 ↗
77. Epigenetic Modulation of Intestinal Cholesterol Transporter Niemann-Pick C1-like 1 (NPC1L1) Gene Expression by DNA Methylation10.1074/jbc.M113.546283 ↗